Both groups exhibited significant decreases ( p < 0.05) in efficacy indicators, with the exception of children’s DLQI, which showed a decreasing trend but did not achieve statistical significance.
← all excerpts
Real-world efficacy and safety of dupilumab in the treatment of head and neck atopic dermatitis: a retrospective cohort study.
1
—
—